Table 3.
Baseline PVA | Follow-up PVA | |||
---|---|---|---|---|
20/20-20/63 | <20/63-20/200 | <20/200 | ALL | |
20/20-20/63 | 28 (54.8%) | 1 (2.0%) | 1 (2.0%) | 30 (58.8%) |
18 (26.1%) | 2 (2.8%) | 0 (0.0%) | 20 (28.9%) | |
<20/63-20/200 | 10 (19.6%) | 2 (3.9%) | 0 (0.0%) | 12 (23.5%) |
16 (23.3%) | 4 (5.7%) | 1 (1.4%) | 21 (30.4%) | |
<20/200 | 4 (7.9%) | 3 (5.9%) | 2 (3.9%) | 9 (17.7%) |
16 (23.2%) | 5 (7.3%) | 7 (10.2%) | 28 (40.7%) | |
ALL | 42 (82.3%) | 6 (11.8%) | 3 (5.9%) | 51 (100.0%) |
50 (72.6%) | 11 (15.8%) | 8 (11.6%) | 69 (100.0%) |
Note: Top line refers to 51 participants and bottom line (italics) refers to cataract-operated eyes.